Arizona State Fair Sees Record Attendance Turnout in 2021

After a one-year hiatus due to the COVID-19 pandemic, the Arizona State Fair set a new record for 2021. More than 1.6 million people attended the Arizona State Fair which sets a new attendance record for the 116-year-old event. The annual event was held from Oct. 1-30 at the state fairgrounds in Phoenix. The... Read More

United States Removes Pandemic Ban on Nonessential Travel, Border Doors Now Open To Visitors

Foreign travelers are now welcomed back in the U.S. for the first time in over a year and a half, but there are still some restrictions that travelers need to be aware of. Back in March of 2020, COVID-19 concerns sparked the U.S. to close its borders to international travelers from countries including Brazil,... Read More

Black Friday – Who Will Be Closed On Thanksgiving Day?

The Black Friday experience in 2020 was very different due to the COVID-19 pandemic.  While consumers have most definitely shifted gears and increased their online shopping, many still like the thrill of the hunt the day after turkey day and retailers are hoping shoppers return to the in-person experience. Given the concern the country has... Read More

Phoenix Welcomes the Holiday Season With a Plethora of Events

By Lauren Wong With the holiday season right around the corner, get details on your favorite annual and new events. Mark your calendars, purchase tickets if necessary, and feel the joy of the festivities beginning around you. Here are some events to keep on your radar as you plan out the next couple months. ... Read More

Desert Financial Fiesta Bowl Parade In Need of ‘Half-Pint’ Judges

The Desert Financial Fiesta Bowl Parade Presented by Lerner & Rowe is in need of some judges! And not just any judge will do! No one loves a parade more than children, so they are looking for Arizona’s finest to judge from a kids’ perspectives to choose the best parade entries. Arizona children can now... Read More

Pfizer Says its Experimental COVID-19 Pill Reduced Risk of Hospitalization or Death by 90%

Pfizer Inc. announced this week its investigational novel COVID-19 oral antiviral candidate, PAXLOVID™, significantly reduced hospitalization and death, based on an interim analysis of the Phase 2/3 EPIC-HR randomized, double-blind study of non-hospitalized adult patients with COVID-19, who are at high risk of progressing to severe illness. The scheduled interim analysis showed an 89% reduction... Read More